Skip to content
OpenCapital
Get started

Medpace Holdings, Inc. MEDP Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied

Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
——
IQVIA logo
IQVIAIQV
——
Tenet Healthcare logo
Tenet HealthcareTHC
——
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
——

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied?
Medpace Holdings, Inc. (MEDP) reported remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied of $3.5B in Q1 2026.
How has Medpace Holdings, Inc.'s remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied changed year-over-year?
Medpace Holdings, Inc.'s remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied increased by 2.9% year-over-year, from $3.4B to $3.5B.
What is the long-term trend for Medpace Holdings, Inc.'s remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied?
Over 2 years (2023 to 2025), Medpace Holdings, Inc.'s remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied has grown at a 11.4% compound annual growth rate (CAGR), from $2.9B to $3.6B.